Constitutive STAT5 activation in precursor B-cell acute lymphoblastic leukemia with P2RY8::CRLF2 fusion No … ← Targeting therapeutic vulnerabilities in T-PLL Genetic alteration of class I HLA in cutaneous T-cell lymphoma →